Credo Life Science
Posted on 27th January 2022

Posted on 27th January 2022

Pancreatin — a complex mixture of digestive enzymes including lipase, amylase, and protease — is a critical biopharmaceutical used in enzyme replacement therapy (ERT) for pancreatic insufficiency. Sourcing from a reliable Pancreatin Manufacturer is essential given the biological complexity and strict regulatory requirements of this product.
Unlike synthetic APIs, Pancreatin is derived from porcine pancreatic tissue, introducing unique challenges: biological variability, enzyme activity standardisation, and TSE (Transmissible Spongiform Encephalopathy) safety requirements. A qualified Pancreatin Manufacturer must navigate these challenges with robust sourcing controls, validated manufacturing processes, and rigorous enzyme activity testing.
Credo Life Sciences has established itself as a globally preferred Pancreatin Manufacturer by combining rigorous biological sourcing controls with advanced pharmaceutical manufacturing capabilities. Our Pancreatin is standardised to meet USP and Ph. Eur. enzyme activity specifications, supported by validated analytical methods for lipase, amylase, and protease activity.
Our Pancreatin manufacturing adheres to WHO-GMP standards. We provide comprehensive regulatory support including TSE certificates of suitability, batch records, CoA, stability data, and support for dossier preparation in EU, US, and emerging market formats.
When quality, safety, and compliance are non-negotiable, Credo Life Sciences is the Pancreatin Manufacturer you can trust. Partner with us to bring high-quality enzyme replacement therapies to patients worldwide.